Genta, Inc. (GNTA) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Genta, Inc. (GNTA)

GNTA 2.310

+0.4%

2:42 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: John Nobrega who started this subject	6/3/2002 1:04:46 PM
From: bob zagorin	Read Replies (1) of 1870

Monday June 3, 12:02 pm Eastern Time Reuters Company News RESEARCH ALERT-Genta cut on delay of clinical trial NEW YORK, June 3 (Reuters) - UBS Warburg on Monday said it cut its stock rating on Genta Inc. (NasdaqNM:GNTA - News) to a "hold" from "buy" on the delay of a late stage clinical trial of its lead product, cancer drug Genasense. Analyst Andrew Gitkin at UBS lowered the rating following a conference call with the company earlier in the day.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next